Balentine LLC’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-824
Closed -$275K 342
2024
Q1
$275K Buy
824
+52
+7% +$15.9K 0.01% 418
2023
Q4
$209K Sell
772
-258
-25% -$63.8K 0.01% 475
2023
Q3
$253K Buy
1,030
+43
+4% +$11.8K 0.01% 404
2023
Q2
$300K Buy
987
+81
+9% +$22.5K 0.01% 380
2023
Q1
$239K Buy
906
+28
+3% +$7.11K 0.01% 470
2022
Q4
$211K Buy
+878
New +$197K 0.01% 528
2020
Q3
Sell
-86
Closed -$8K 461
2020
Q2
$8K Sell
86
-8
-9% -$832 ﹤0.01% 602
2020
Q1
$8K Sell
94
-282
-75% -$36.5K ﹤0.01% 406
2019
Q4
$56K Buy
376
+331
+736% +$44.4K ﹤0.01% 173
2019
Q3
$5K Buy
45
+10
+29% +$1.29K ﹤0.01% 524
2019
Q2
$5K Buy
+35
New +$4.42K ﹤0.01% 493
2015
Q4
Sell
-686
Closed -$53K 436
2015
Q3
$53K Sell
686
-125
-15% -$11.1K 0.01% 164
2015
Q2
$74K Hold
811
0.01% 116
2015
Q1
$61K Buy
+811
New +$58.2K 0.01% 121

Other funds holding HCA

Balentine LLC's HCA Position: Q2 2024 in Review

Balentine LLC sold out of HCA Healthcare (HCA) in Q2 2024, closing a stake of 824 shares — an estimated $275K sold.

Balentine LLC first reported a position in HCA in Q1 2015 and held it in 14 quarters. The position peaked at $300K in Q2 2023. 1,155 funds tracked by Wall St. Rank hold HCA as of Q2 2024.

  • Balentine LLC reported no remaining HCA Healthcare position as of Q2 2024 after selling out during the quarter.
  • Balentine LLC sold 824 HCA Healthcare shares in Q2 2024, an estimated $275K.
  • Balentine LLC first reported a position in HCA Healthcare in Q1 2015 and held it in 14 quarters.
  • Balentine LLC's HCA Healthcare position peaked at $300K in Q2 2023.
  • 1,155 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.